317 related articles for article (PubMed ID: 19672905)
21. OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells.
Mousavi SF; Soroosh P; Takahashi T; Yoshikai Y; Shen H; Lefrançois L; Borst J; Sugamura K; Ishii N
J Immunol; 2008 Nov; 181(9):5990-6001. PubMed ID: 18941188
[TBL] [Abstract][Full Text] [Related]
22. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion.
Maxwell JR; Weinberg A; Prell RA; Vella AT
J Immunol; 2000 Jan; 164(1):107-12. PubMed ID: 10605000
[TBL] [Abstract][Full Text] [Related]
23. Exogenous OX40 stimulation during lymphocytic choriomeningitis virus infection impairs follicular Th cell differentiation and diverts CD4 T cells into the effector lineage by upregulating Blimp-1.
Boettler T; Choi YS; Salek-Ardakani S; Cheng Y; Moeckel F; Croft M; Crotty S; von Herrath M
J Immunol; 2013 Nov; 191(10):5026-35. PubMed ID: 24101548
[TBL] [Abstract][Full Text] [Related]
24. During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion.
Hendriks J; Xiao Y; Rossen JW; van der Sluijs KF; Sugamura K; Ishii N; Borst J
J Immunol; 2005 Aug; 175(3):1665-76. PubMed ID: 16034107
[TBL] [Abstract][Full Text] [Related]
25. The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice.
Salek-Ardakani S; Flynn R; Arens R; Yagita H; Smith GL; Borst J; Schoenberger SP; Croft M
J Clin Invest; 2011 Jan; 121(1):296-307. PubMed ID: 21183789
[TBL] [Abstract][Full Text] [Related]
26. OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T Cells: A CD4-dependent mechanism.
Humphreys IR; Loewendorf A; de Trez C; Schneider K; Benedict CA; Munks MW; Ware CF; Croft M
J Immunol; 2007 Aug; 179(4):2195-202. PubMed ID: 17675479
[TBL] [Abstract][Full Text] [Related]
27. PD-1 blockade and OX40 triggering synergistically protects against tumor growth in a murine model of ovarian cancer.
Guo Z; Wang X; Cheng D; Xia Z; Luan M; Zhang S
PLoS One; 2014; 9(2):e89350. PubMed ID: 24586709
[TBL] [Abstract][Full Text] [Related]
28. Functional dichotomy between OX40 and 4-1BB in modulating effector CD8 T cell responses.
Lee SW; Park Y; Song A; Cheroutre H; Kwon BS; Croft M
J Immunol; 2006 Oct; 177(7):4464-72. PubMed ID: 16982882
[TBL] [Abstract][Full Text] [Related]
29. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ
J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935
[TBL] [Abstract][Full Text] [Related]
30. Ligation of CD137 receptor prevents and reverses established anergy of CD8+ cytolytic T lymphocytes in vivo.
Wilcox RA; Tamada K; Flies DB; Zhu G; Chapoval AI; Blazar BR; Kast WM; Chen L
Blood; 2004 Jan; 103(1):177-84. PubMed ID: 12969968
[TBL] [Abstract][Full Text] [Related]
31. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.
Dawicki W; Bertram EM; Sharpe AH; Watts TH
J Immunol; 2004 Nov; 173(10):5944-51. PubMed ID: 15528328
[TBL] [Abstract][Full Text] [Related]
32. Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8
Peng W; Williams LJ; Xu C; Melendez B; McKenzie JA; Chen Y; Jackson HL; Voo KS; Mbofung RM; Leahey SE; Wang J; Lizee G; Tawbi HA; Davies MA; Hoos A; Smothers J; Srinivasan R; Paul EM; Yanamandra N; Hwu P
Clin Cancer Res; 2019 Nov; 25(21):6406-6416. PubMed ID: 31371342
[TBL] [Abstract][Full Text] [Related]
33. Synergistic OX40 and CD30 signals sustain CD8+ T cells during antigenic challenge.
Bekiaris V; Gaspal F; Kim MY; Withers DR; Sweet C; Anderson G; Lane PJ
Eur J Immunol; 2009 Aug; 39(8):2120-5. PubMed ID: 19609980
[TBL] [Abstract][Full Text] [Related]
34. Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells.
Rathmell JC; Fournier S; Weintraub BC; Allison JP; Goodnow CC
J Exp Med; 1998 Aug; 188(4):651-9. PubMed ID: 9705947
[TBL] [Abstract][Full Text] [Related]
35. OX40 drives protective vaccinia virus-specific CD8 T cells.
Salek-Ardakani S; Moutaftsi M; Crotty S; Sette A; Croft M
J Immunol; 2008 Dec; 181(11):7969-76. PubMed ID: 19017988
[TBL] [Abstract][Full Text] [Related]
36. Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulation.
Bandyopadhyay S; Long M; Qui HZ; Hagymasi AT; Slaiby AM; Mihalyo MA; Aguila HL; Mittler RS; Vella AT; Adler AJ
J Immunol; 2008 Dec; 181(11):7728-37. PubMed ID: 19017962
[TBL] [Abstract][Full Text] [Related]
37. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.
Gramaglia I; Jember A; Pippig SD; Weinberg AD; Killeen N; Croft M
J Immunol; 2000 Sep; 165(6):3043-50. PubMed ID: 10975814
[TBL] [Abstract][Full Text] [Related]
38. Conversion of alloantigen-specific CD8+ T cell anergy to CD8+ T cell priming through in vivo ligation of glucocorticoid-induced TNF receptor.
Kim J; Choi WS; Kang H; Kim HJ; Suh JH; Sakaguchi S; Kwon B
J Immunol; 2006 May; 176(9):5223-31. PubMed ID: 16621987
[TBL] [Abstract][Full Text] [Related]
39. Clonal anergy induced in a CD8+ hapten-specific cytotoxic T-cell clone by an altered hapten-peptide ligand.
Preckel T; Hellwig S; Pflugfelder U; Lappin MB; Weltzien HU
Immunology; 2001 Jan; 102(1):8-14. PubMed ID: 11168631
[TBL] [Abstract][Full Text] [Related]
40. OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses.
Goulding J; Tahiliani V; Salek-Ardakani S
Immunol Rev; 2011 Nov; 244(1):149-68. PubMed ID: 22017437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
